SANUWAVE Health Announces Board and Executive Changes
Ticker: SNWV · Form: 8-K · Filed: Oct 25, 2024 · CIK: 1417663
| Field | Detail |
|---|---|
| Company | Sanuwave Health, Inc. (SNWV) |
| Form Type | 8-K |
| Filed Date | Oct 25, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $14 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, board-of-directors, compensation
Related Tickers: SNWV
TL;DR
SANUWAVE Health shakes up board and exec pay - new era begins?
AI Summary
SANUWAVE Health, Inc. announced on October 22, 2024, a change in its board of directors and executive compensation arrangements. The filing details the departure of certain officers and the election of new directors, alongside adjustments to compensatory plans for key personnel.
Why It Matters
Changes in a company's board and executive compensation can signal shifts in strategy, operational focus, or financial outlook, impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Changes in leadership and compensation can introduce uncertainty regarding future strategy and execution, potentially impacting the company's stability and performance.
Key Players & Entities
- SANUWAVE Health, Inc. (company) — Registrant
- Nevada (jurisdiction) — State of incorporation
- October 22, 2024 (date) — Date of earliest event reported
FAQ
What specific roles have been affected by the departure of officers?
The filing indicates the departure of certain officers but does not specify the exact roles in this summary.
Who are the newly elected directors?
The filing mentions the election of directors but does not list their names in this summary.
What are the key changes in the compensatory arrangements?
The filing notes adjustments to compensatory arrangements for certain officers, but the specifics are not detailed in this summary.
What is the primary reason cited for these changes?
The filing does not provide a specific reason for these changes in the provided text.
When did these changes become effective?
The earliest event reported is dated October 22, 2024.
Filing Stats: 555 words · 2 min read · ~2 pages · Grade level 11.8 · Accepted 2024-10-25 16:36:11
Key Financial Figures
- $14 — ave a per share exercise price equal to $14.20, which was the closing price per sha
Filing Documents
- snwv-20241022.htm (8-K) — 31KB
- ex101formofstockoptiongran.htm (EX-10.1) — 42KB
- 0001628280-24-043824.txt ( ) — 193KB
- snwv-20241022.xsd (EX-101.SCH) — 2KB
- snwv-20241022_lab.xml (EX-101.LAB) — 20KB
- snwv-20241022_pre.xml (EX-101.PRE) — 11KB
- snwv-20241022_htm.xml (XML) — 2KB
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 10.1 Form of Stock Option Award Agreement under the SANUWAVE Health, Inc. 2024 Equity Incentive Plan 104 Cover Page Interactive Data File--the cover page XBRL tags are embedded within the Inline XBRL document.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SANUWAVE HEALTH, INC. Dated: October 25, 2024 By: /s/ Peter Sorensen Name: Peter Sorensen Title: Chief Financial Officer